Coherus BioSciences Inc (NASDAQ:CHRS)

12.09
Delayed Data
As of Oct 23
 0.00 / 0.00%
Today’s Change
8.05
Today|||52-Week Range
20.66
+37.39%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$820.0M

Company Description

Coherus BioSciences, Inc. is a late-stage clinical biologics platform company, which engages in the development and commercialization of biosimilar therapeutics. Its clinical products include pegfilgrastim biosimilar, adalimumab biosimilar, etanercept biosimilar, ranibizumab biosimilar, and aflibercept biosimilar. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar, and Steve Glover in September 2010 and is headquartered in Redwood City, CA.

Contact Information

Coherus BioSciences, Inc.
333 Twin Dolphin Drive
Redwood City California 94065
P:(650) 649-3530
Investor Relations:

Employees

Shareholders

Other institutional41.80%
Mutual fund holders41.49%
Individual stakeholders32.40%

Top Executives

Denny M. LanfearChairman, President & Chief Executive Officer
Jean-Frédéric ViretChief Financial Officer
Alan C. HermanChief Scientific Officer
Peter K. WatlerChief Technical Officer
Barbara K. FinckChief Medical Officer